These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28450396)

  • 1. Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain.
    Lei W; Mullen N; McCarthy S; Brann C; Richard P; Cormier J; Edwards K; Bilsky EJ; Streicher JM
    J Biol Chem; 2017 Jun; 292(25):10414-10428. PubMed ID: 28450396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp90β positively regulates μ-opioid receptor function.
    Zhang Y; Zhou P; Wang Z; Chen M; Fu F; Su R
    Life Sci; 2020 Jul; 252():117676. PubMed ID: 32304763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Hsp90 in the spinal cord enhances the antinociceptive effects of morphine by activating an ERK-RSK pathway.
    Duron DI; Lei W; Barker NK; Stine C; Mishra S; Blagg BSJ; Langlais PR; Streicher JM
    Sci Signal; 2020 May; 13(630):. PubMed ID: 32371496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSP90 inhibitors strengthen extracellular ATP-stimulated synthesis of interleukin-6 in osteoblasts: Amplification of p38 MAP kinase.
    Hioki T; Tokuda H; Nakashima D; Fujita K; Kawabata T; Sakai G; Kim W; Tachi J; Tanabe K; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O
    Cell Biochem Funct; 2021 Jan; 39(1):88-97. PubMed ID: 32567086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Alpha Isoform of Heat Shock Protein 90 and the Co-chaperones p23 and Cdc37 Promote Opioid Anti-nociception in the Brain.
    Lei W; Duron DI; Stine C; Mishra S; Blagg BSJ; Streicher JM
    Front Mol Neurosci; 2019; 12():294. PubMed ID: 31849607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression.
    Georgakis GV; Li Y; Rassidakis GZ; Medeiros LJ; Younes A
    Exp Hematol; 2006 Dec; 34(12):1670-9. PubMed ID: 17157164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model.
    Joshi SS; Jiang S; Unni E; Goding SR; Fan T; Antony PA; Hornyak TJ
    PLoS One; 2018; 13(2):e0191264. PubMed ID: 29481571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.
    Lang SA; Klein D; Moser C; Gaumann A; Glockzin G; Dahlke MH; Dietmaier W; Bolder U; Schlitt HJ; Geissler EK; Stoeltzing O
    Mol Cancer Ther; 2007 Mar; 6(3):1123-32. PubMed ID: 17363505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
    Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
    Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp90 Inhibitor Attenuates the Development of Pathophysiological Cardiac Fibrosis in Mouse Hypertrophy via Suppression of the Calcineurin-NFAT and c-Raf-Erk Pathways.
    Marunouchi T; Nakashima M; Ebitani S; Umezu S; Karasawa K; Yano E; Tanonaka K
    J Cardiovasc Pharmacol; 2021 Jun; 77(6):822-829. PubMed ID: 34016843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSP90 inhibitors induce desensitization of EGF receptor via p38 MAPK-mediated phosphorylation at Ser1046/1047 in human pancreatic cancer cells.
    Adachi S; Yasuda I; Nakashima M; Yamauchi T; Yamauchi J; Natsume H; Moriwaki H; Kozawa O
    Oncol Rep; 2010 Jun; 23(6):1709-14. PubMed ID: 20428829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsp90 modulates human sperm capacitation via the Erk1/2 and p38 MAPK signaling pathways.
    Sun P; Wang Y; Gao T; Li K; Zheng D; Liu A; Ni Y
    Reprod Biol Endocrinol; 2021 Mar; 19(1):39. PubMed ID: 33663544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition.
    Guo W; Reigan P; Siegel D; Zirrolli J; Gustafson D; Ross D
    Cancer Res; 2005 Nov; 65(21):10006-15. PubMed ID: 16267026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK inhibition potentiates the activity of Hsp90 inhibitor 17-AAG against pancreatic cancer cells.
    Zhang T; Li Y; Zhu Z; Gu M; Newman B; Sun D
    Mol Pharm; 2010 Oct; 7(5):1576-84. PubMed ID: 20669973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of heat shock protein 90 in regulating pain, opioid signaling, and opioid antinociception.
    Streicher JM
    Vitam Horm; 2019; 111():91-103. PubMed ID: 31421708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90.
    Sydor JR; Normant E; Pien CS; Porter JR; Ge J; Grenier L; Pak RH; Ali JA; Dembski MS; Hudak J; Patterson J; Penders C; Pink M; Read MA; Sang J; Woodward C; Zhang Y; Grayzel DS; Wright J; Barrett JA; Palombella VJ; Adams J; Tong JK
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17408-13. PubMed ID: 17090671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53-dependent radiosensitizing effects of Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin on human oral squamous cell carcinoma cell lines.
    Shintani S; Zhang T; Aslam A; Sebastian K; Yoshimura T; Hamakawa H
    Int J Oncol; 2006 Nov; 29(5):1111-7. PubMed ID: 17016641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP90 inhibitors diminish PDGF-BB-induced migration of osteoblasts via suppression of p44/p42 MAP kinase.
    Kawabata T; Tokuda H; Fujita K; Matsushima-Nishiwaki R; Sakai G; Tachi J; Hioki T; Kim W; Iida H; Otsuka T; Kozawa O
    Biomed Res; 2019; 40(4):169-178. PubMed ID: 31413238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein 90 inhibitors block the antinociceptive effects of opioids in mouse chemotherapy-induced neuropathy and cancer bone pain models.
    Stine C; Coleman DL; Flohrschutz AT; Thompson AL; Mishra S; Blagg BS; Largent-Milnes TM; Lei W; Streicher JM
    Pain; 2020 Aug; 161(8):1798-1807. PubMed ID: 32701840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.